Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer

NDAQ:APHA - Post by User

Aphria Inc.

Bullboard Posts

Comment by Montevialeon Jan 13, 2018 8:04am

228 Views

Post# 27348520

RE:RE:CSE News leaves investors hanging

PrZ, for someone who doesn't own any shares in Aphria you sure spend a lot of time on this board.

With over 20 companies now listed on the CSE doing business in the US I certainly welcome new policy changes that may be forthcoming that will provide investors with more information and not less. Additional disclosure by all companies is a good thing and would be great for the sector.

For those that don't want exposure to the US market, such as yourself, there are many investing options that provide you with no exposure to what is undoubtly becoming the largest cannabis market in the world.

If you are an investor in the Cannabis space at some point you too will have exposure to Canadian listed companies that are doing business in the US, even if you're late arriving at the party.

So what you perceive as bad for the sector is actually an opportunity for those wanting exposure to the US.

Once again, I can explain it to you but I can't make you understand it.

M